GproteinDb

desmopressin

Agent/drug
Bioactivity

desmopressin

SMILES	N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O
InChIKey	NFLWUMRGJYTJIN-PNIOQBSNSA-N

Chemical Properties

Hydrogen bond acceptors	15
Hydrogen bond donors	14
Rotatable bonds	19
Molecular weight (Da)	1068.4

Database connections

PubChem ChEMBL_compound_ids PubChem DrugBank PubChem GPCRdb

No bioactivity data available.

desmopressin

Drug properties

Molecular type	Small molecule
Physiological/Surrogate	Surrogate
Approved drug	Yes

Distribution across phases (no. indications)

Phase I 3

Phase II 12

Phase III 6

Phase IV 12

Database connections

PubChem ChEMBL_compound_ids PubChem DrugBank PubChem GPCRdb

Sankey plot

Drug Information

Search:

Target					Disease

Gene	Protein	Receptor family	Ligand type	Class	Name	Phase	ICD11	ATC	Association score

V1AR	V_1A receptor	Vasopressin and oxytocin receptors	Peptide receptors	A	Central diabetes insipidus	4	5A61.5	H01B	0.566
V1AR	V_1A receptor	Vasopressin and oxytocin receptors	Peptide receptors	A	Enuresis, unspecified	4	6C00.Z	H01B	0.586
V1AR	V_1A receptor	Vasopressin and oxytocin receptors	Peptide receptors	A	Intracerebral haemorrhage, site unspecified	2	8B00.Z	H01B	0.092
V1AR	V_1A receptor	Vasopressin and oxytocin receptors	Peptide receptors	A	Leptospirosis	3	1B91	H01B	0.074
V1AR	V_1A receptor	Vasopressin and oxytocin receptors	Peptide receptors	A	Malignant neoplasms of breast, unspecified	2	2C6Z	H01B	0.074
V1AR	V_1A receptor	Vasopressin and oxytocin receptors	Peptide receptors	A	Malignant neoplasms of prostate, unspecified	1	2C82.Z	H01B	0.018
V1AR	V_1A receptor	Vasopressin and oxytocin receptors	Peptide receptors	A	Nasal congestion	4	MD11.9	H01B	0.565
V1AR	V_1A receptor	Vasopressin and oxytocin receptors	Peptide receptors	A	Overactive bladder	2	GC50.0	H01B	0.074
V1AR	V_1A receptor	Vasopressin and oxytocin receptors	Peptide receptors	A	Renal colic	3	MF56	H01B	0.259
V1AR	V_1A receptor	Vasopressin and oxytocin receptors	Peptide receptors	A	Superficial injury of unspecified body region	2	ND56.0	H01B	0.092
V1AR	V_1A receptor	Vasopressin and oxytocin receptors	Peptide receptors	A	Von Willebrand disease	4	3B12	H01B	0.462
V1BR	V_1B receptor	Vasopressin and oxytocin receptors	Peptide receptors	A	Central diabetes insipidus	4	5A61.5	H01B	0.566
V1BR	V_1B receptor	Vasopressin and oxytocin receptors	Peptide receptors	A	Enuresis, unspecified	4	6C00.Z	H01B	0.586
V1BR	V_1B receptor	Vasopressin and oxytocin receptors	Peptide receptors	A	Intracerebral haemorrhage, site unspecified	2	8B00.Z	H01B	0.092
V1BR	V_1B receptor	Vasopressin and oxytocin receptors	Peptide receptors	A	Leptospirosis	3	1B91	H01B	0.074
V1BR	V_1B receptor	Vasopressin and oxytocin receptors	Peptide receptors	A	Malignant neoplasms of breast, unspecified	2	2C6Z	H01B	0.074
V1BR	V_1B receptor	Vasopressin and oxytocin receptors	Peptide receptors	A	Malignant neoplasms of prostate, unspecified	1	2C82.Z	H01B	0.018
V1BR	V_1B receptor	Vasopressin and oxytocin receptors	Peptide receptors	A	Nasal congestion	4	MD11.9	H01B	0.565
V1BR	V_1B receptor	Vasopressin and oxytocin receptors	Peptide receptors	A	Overactive bladder	2	GC50.0	H01B	0.074
V1BR	V_1B receptor	Vasopressin and oxytocin receptors	Peptide receptors	A	Renal colic	3	MF56	H01B	0.259

Showing 1 to 20 of 33 entries

Join us

Cite us

Main reference

desmopressin

desmopressin

Chemical Properties

Database connections

No bioactivity data available.

desmopressin

Drug properties

Distribution across phases (no. indications)

Database connections

Sankey plot

Drug Information